Cipla betting big on digitisation and emerging segments
The drugmaker is also bullish on maximising value opportunity in the complex generics in the US market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla Health to acquire Endura Mass From Medinnbelle Herbalcare
The acquisition is in line with Cipla's strategic imperative to augment its wellness portfolio for bringing about a shift from an…
Cipla to invest Rs 26 crores in GoApptiv to raise stake to 22 per cent
Cipla has agreed to acquire an additional stake for nearly Rs 26 crores in digital tech company GoApptiv Private to raise its…
Cipla to acquire 21 per cent stake in Achira Labs for Rs 25 crores
Cipla said the transaction is expected to be completed within 60 days
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV in South Africa
The ‘4-in-1’ combination contains an antiretroviral combination that is recommended by the WHO as an alternative first-line…
Cipla adds capacity of captive renewable energy power plant in Maharashtra and Karnataka
The project will support the company’s green energy requirements for its manufacturing units at Kurkumbh and Patalganga and…
Cipla partners with Genes2Me for commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR test kit
RNA extraction free kit to deliver results in 45 minutes
A seat at the table: Shaping the healthcare policy landscape
While trade agreements with Australia, the UK, Canada and Bangladesh are nearing completion, and discussions with the EU and…
Discerning the next frontier for quality excellence in Indian pharma industry
Express Pharma as part of SAP India's Industry Knowledge Exchange Forum's Expert Speak series, invited pharma quality veteran Dr…
Cipla receives USFDA nod to market Lanreotide injection in US market
The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (FDA)